Imaging inflammation and its resolution in health and disease: current status, clinical needs, challenges, and opportunities-Reference-Cited by-同舟云学术

Imaging inflammation and its resolution in health and disease: current status, clinical needs, challenges, and opportunities

Published:2019-12 Issue:12 Volume:33 Page:13085-13097
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Liu Christina H.¹,Abrams Natalie D.¹,Carrick Danielle M.¹,Chander Preethi²,Dwyer Johanna³,Hamlet Michelle R. J.⁴,Kindzelski Andrei L.⁵,PrabhuDas Mercy⁶,Tsai Shang-Yi Anne⁷,Vedamony Merriline M.⁶,Wang Chiayeng²,Tandon Pushpa¹

Affiliation:

1. National Cancer Institute, (NIH), Rockville, Maryland, USA;

2. National Institute of Dental and Craniofacial Research, (NIH), Bethesda, Maryland, USA;

3. Office of Dietary Supplements, (NIH), Bethesda, Maryland, USA;

4. National Institute of Nursing Research, (NIH), Bethesda, Maryland, USA;

5. National Heart, Lung, and Blood Institute, (NIH), Bethesda, Maryland, USA;

6. National Institute of Allergy and Infectious Diseases, (NIH), Rockville, Maryland, USA;

7. National Institute on Drug Abuse, National Institutes of Health (NIH), Rockville, Maryland, USA

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Reference79 articles.

1. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators

2. Aspirin-triggered proresolving mediators stimulate resolution in cancer

3. Cutting Edge: Human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proinflammatory Eicosanoids

4. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

5. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indole-Based and Cyclopentenylindole-Based Analogues Containing Fluorine Group as Potential 18F-Labeled Positron Emission Tomography (PET) G-Protein Coupled Receptor 44 (GPR44) Tracers;Pharmaceuticals;2023-08-24

2. Activatable Nanoreporters for Real‐Time Tracking of Macrophage Phenotypic States Associated with Disease Progression;Small;2023-06-14

3. Comparison of PIC and EDTA-coupled acetamidobenzoxazolone probes as a specific marker for a 18 kDa protein (TSPO);New Journal of Chemistry;2023

4. Imaging Approaches to Monitor Inflammasome Activation;Journal of Molecular Biology;2022-02

5. Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies;Genes & Diseases;2021-10